Daratumumab for eradication of minimal residual disease in high-risk advanced relapse of T-cell/CD19/CD22-negative acute lymphoblastic leukemiaYishai Ofran, Avraham Frisch, Tsila Zuckerman et al.|Leukemia|2019Cited by 69
Superior outcome of patients with favorable-risk acute myeloid leukemia using consolidation with autologous stem cell transplantationOfrat Beyar‐Katz, Tsila Zuckerman, Jacob M. Rowe et al.|Leukemia & lymphoma/Leukemia and lymphoma|2019Cited by 13